Insider Trading: Agenus Inc (AGEN.O)
AGEN.O on Consolidated Issue listed on NASDAQ Capital Market
4.03USD
22 May 2013
4.03USD
22 May 2013
Price Change (% chg)
$0.02 (+0.50%)
$0.02 (+0.50%)
Prev Close
$4.01
$4.01
Open
$4.01
$4.01
Day's High
$4.23
$4.23
Day's Low
$4.00
$4.00
Volume
167,024
167,024
Avg. Vol
160,692
160,692
52-wk High
$5.99
$5.99
52-wk Low
$3.37
$3.37
VALENTINE KAREN HIGGINS
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 27 Jan 2013 | Buy | 417 | $4.35 | 29,384 |
| 25 Oct 2012 | Buy | 417 | $4.42 | 28,967 |
| 11 Sep 2012 | Buy | 2,410 | $0.00 | 28,550 |
| 25 Jul 2012 | Buy | 416 | $4.61 | 26,140 |
| 20 Jun 2012 | Sell | 2,899 | $5.05 | 25,724 |
| 19 Jun 2012 | Sell | 1,564 | $4.92 | 25,724 |
| 18 Jun 2012 | Buy | 10,050 | $5.26 | 25,724 |
| 25 Apr 2012 | Buy | 417 | $6.43 | 20,137 |
| 14 Mar 2012 | Buy | 2,904 | $5.31 | 19,720 |
| 25 Jan 2012 | Buy | 417 | $2.76 | 16,816 |
| 2 Jan 2012 | Buy | 15,208 | $2.17 | 16,399 |
| 28 Dec 2011 | Sell | 7,605 | $1.98 | 1,191 |
| 27 Dec 2011 | Sell | 1,301 | $2.09 | 1,191 |
| 26 Dec 2011 | Sell | 2,169 | $2.14 | 1,191 |
| 22 Dec 2011 | Sell | 608 | $2.20 | 12,266 |
| 21 Dec 2011 | Sell | 1,177 | $2.19 | 12,266 |
| 20 Dec 2011 | Sell | 2,348 | $2.24 | 12,266 |
| 25 Oct 2011 | Buy | 416 | $2.70 | 16,399 |
| 11 Sep 2011 | Buy | 3,334 | $0.55 | 95,902 |
| 25 Jul 2011 | Buy | 2,500 | $0.79 | 92,568 |
Institutional Holders
| % Shares Owned: | 43.88% |
| # of Holders: | 72 |
| Total Shares Held: | 9,981,101 |
| 3 Mo. Net Change: | 2,057,586 |
| # New Positions: | 6 |
| # Closed Positions: | 11 |
| # Increased Positions: | 35 |
| # Reduced Positions: | 29 |
| # Net Buyers: | 6 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Garo Armen |
59 | 1999 | Chairman of the Board, Chief Executive Officer |
Christine Klaskin |
46 | 2012 | Principal Financial Officer, Principal Accounting Officer |
Karen Valentine |
40 | 2010 | Vice President, Chief Compliance Officer, General Counsel, Secretary |
Kerry Wentworth |
39 | Vice President - Clinical, Regulatory & Quality | |
Timothy Wright |
54 | 2009 | Lead Independent Director |
Shalini Sharp |
37 | 2012 | Director |
Brian Corvese |
54 | 2007 | Independent Director |
Tom Dechaene |
54 | 2009 | Independent Director |
Wadih Jordan |
77 | 2003 | Independent Director |
Jonae Barnes |
Vice President - Investor Relations and Corporate Communications |

